Skip to content
Fencer Intel
medium 5.3

CVE-2025-47149 json

The optional feature 'Anti-Virus & Sandbox' of i-FILTER contains an issue with improper pattern file validation.

published last yr. modified 4mo ago also EUVD-2025-28078

cvss
5.3
version 3.0, CNA
cisa kev
Not listed
not in CISA's catalog
epss
0.2%
EPSS 0.2% chance of exploitation in 30 days, percentile 6%
public exploits
0
none known

Summary

The optional feature 'Anti-Virus & Sandbox' of i-FILTER contains an issue with improper pattern file validation. If exploited, the product may treat an unauthorized pattern file as an authorized. If the product uses a specially crafted pattern file, information in the server where the product is running may be retrieved, and/or cause a denial of service (DoS) condition.

Patch / fix

  • daj i-filter 10.67r03

Is CVE-2025-47149 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.

Check with Fencer

CISA SSVC

Exploitation
none
Automatable
yes
Technical impact
partial
Assessed
last yr.

Exploit prediction

0.17% chance of exploitation in the next 30 days, higher than 6% of all scored CVEs (FIRST EPSS, 2026-11-09).

CVSS scores

assigned by version score vector
CNA 3.0 5.3 CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N
CNA 4.0 6.9 CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N
CNA 4.0 6.9 CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Affected products

  • Digital Arts Inc. i-FILTER

Classification

Weakness
  • CWE-348 Use of Less Trusted Source

References

Sources

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.

CPEs and fixed versions use Anchore's correction of NVD's data: Added CPE configurations because not yet analyzed by NVD.